Study on Pharmacological Action of Angelica Sinensis Polysaccharide

Therapeutic Effect of Angelica Sinensis Polysaccharide on Alleviating Oxidative Stress in Chronic Bone Diseases

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052891

Enrollment

Unknown

Registered

2021-11-06

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

Control group:No

Therapy group:ASP(Angelica Sinensis Polysaccharide)

Eligibility

Sex/Gender

All

Age

60 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients admitted for total knee arthroplasty; 2. The admission diagnosis was knee osteoarthritis.

Exclusion criteria

Exclusion criteria: After admission examination, it was judged that the operation could not be tolerated.

Design outcomes

Primary

Measure	Time frame
Oxidative stress;Inflammatory markers;Apoptosis;	—

Countries

China

Contacts

Public ContactZhuang Chao

The Affiliated Changzhou Second People's Hospital of Nanjing Medical University

zhuangchao911@163.com+86 13584328757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026